OverviewChartNewsTraderScreen

UBS Knock-Out BIIB/  DE000UM4R0A4  /

UBS Investment Bank
2024-06-14  9:55:39 PM Chg.-0.030 Bid- Ask- Underlying Strike price Expiration date Option type
0.980EUR -2.97% -
Bid Size: -		 -
Ask Size: -		 Biogen Inc 126.9399 USD 2078-12-31 Call
GlobeNewswire 06-15 BIOGEN STOCK NOTICE: Lose Money on your Biogen Inc. (Nasdaq: BIIB) Investment? BFA Law Encourages Yo...
GlobeNewswire 06-14 DEADLINE ALERT for CMBM, BIIB, DRCT, and FSLY: The Law Offices of Frank R. Cruz Reminds Investors of...
GlobeNewswire 06-14 Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire 06-14 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire 06-13 Kirby McInerney LLP Reminds Biogen, Inc. (BIIB) Investors of Class Action Filing and Encourages Inve...
GlobeNewswire 06-13 Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors
GlobeNewswire 06-13 DEADLINE ALERT for BIIB, DRCT, FSLY, CRGE: Law Offices of Howard G. Smith Reminds Investors of Class...
GlobeNewswire 06-13 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
GlobeNewswire 06-13 BIOGEN LEGAL DEADLINE: If You Lost Money on Your Biogen Inc. (Nasdaq: BIIB) Investment, You are Enco...
GlobeNewswire 06-13 BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...
GlobeNewswire 06-12 BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Fir...
GlobeNewswire 06-11 Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 06-11 Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill Ha...
GlobeNewswire 06-11 Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire 06-11 BIOGEN NOTICE: If You Suffered Losses on Your Biogen Inc. (Nasdaq: BIIB) Investment, You are Reminde...
TeleTrader 06-10 FDA advisors endorse Eli Lilly's Alzheimer's drug
GlobeNewswire 06-10 BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class ...
GlobeNewswire 06-10 Biogen Inc. Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges BIIB Investors with Losses to C...
GlobeNewswire 06-10 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire 06-10 FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application f...
GlobeNewswire 06-08 BIOGEN CASE DEADLINE: Biogen Inc. (Nasdaq: BIIB) Investors are Reminded of Upcoming July 2024 Legal ...
GlobeNewswire 06-07 BIIB Class Action Reminder: Contact Robbins LLP for Information About Your Rights Against Biogen Inc...
GlobeNewswire 06-07 Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) S...
GlobeNewswire 06-07 DEADLINE ALERT for CMBM, BIIB, DRCT, and FSLY: The Law Offices of Frank R. Cruz Reminds Investors of...